Evidence map›Paper›PMID 38833775›Full record

ArticleThe International journal on drug policy2024

Breaking barriers: Supporting a syndemics approach to hepatitis C elimination.

Megan Rose Curtis, Laura Marks, Madeline McCrary

Abstract readEditorial
PubMed Full text at PMC Publisher
In one paragraph

Article in The International journal on drug policy, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Megan Rose CurtisMedical Practice Evaluation Center, Massachusetts General Hospital, Boston, MA, USA. Electronic address: mcurtis0@mgh.harvard.edu.
Laura MarksDivision of Infectious Diseases, Department of Medicine, Washington University School of Medicine, St. Louis, MO, USA.
Madeline McCraryDivision of Infectious Diseases, Department of Medicine, Washington University School of Medicine, St. Louis, MO, USA.

Funding

Utilization of health services after engagement with opioid use disorder (OUD) treatment provider by individuals with and without post-traumatic stress disorderP30DA040500 · NIDA · WEILL MEDICAL COLL OF CORNELL UNIV · PI ZACHARY Franklin MEISEL · 2015 to 2026
$20.7M
PROGRAM FOR AIDS CLINICAL RESEARCH TRAINING (PACRT)T32AI007433 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI MARK J SIEDNER · 1992 to 2026
$11.4M
BU Clinical HIV/AIDS Research Training Program (BU-CHART)T32AI052074 · NIAID · BOSTON UNIVERSITY MEDICAL CAMPUS · PI Benjamin P. Linas · 2003 to 2026
$6.7M
NIAID NIH HHS L30 AI178761NIAID NIH HHS T32 AI007433NIAID NIH HHS T32 AI052074NIDA NIH HHS P30 DA040500
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Hepatitis CSyndemicDisease EradicationHumansSubstance Abuse, IntravenousHarm reductionHepatitis C eliminationHousing interventionsMedications for opioid use disorderPeople who inject drugs

Identifiers

PMID38833775
PMCPMC11305914

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.